BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 17083096)

  • 1. Transcranial brain sonography findings in clinical subgroups of idiopathic Parkinson's disease.
    Walter U; Dressler D; Wolters A; Wittstock M; Benecke R
    Mov Disord; 2007 Jan; 22(1):48-54. PubMed ID: 17083096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease.
    Walter U; Dressler D; Probst T; Wolters A; Abu-Mugheisib M; Wittstock M; Benecke R
    Arch Neurol; 2007 Nov; 64(11):1635-40. PubMed ID: 17998447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
    Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
    Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sonographic discrimination of dementia with Lewy bodies and Parkinson's disease with dementia.
    Walter U; Dressler D; Wolters A; Wittstock M; Greim B; Benecke R
    J Neurol; 2006 Apr; 253(4):448-54. PubMed ID: 16267638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcranial sonography findings related to non-motor features of Parkinson's disease.
    Walter U; Skoloudík D; Berg D
    J Neurol Sci; 2010 Feb; 289(1-2):123-7. PubMed ID: 19735925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sonography for diagnosis of Parkinson disease-from theory to practice: a study on 300 participants.
    Alonso-Cánovas A; López-Sendón JL; Buisán J; deFelipe-Mimbrera A; Guillán M; García-Barragán N; Corral I; Matute-Lozano MC; Masjuan J; Martínez-Castrillo JC; Walter U
    J Ultrasound Med; 2014 Dec; 33(12):2069-74. PubMed ID: 25425362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson's Disease.
    Zhou HY; Huang P; Sun Q; Du JJ; Cui SS; Tan YY; Hu YY; Zhan WW; Wang Y; Xiao Q; Liu J; Chen SD
    J Parkinsons Dis; 2018; 8(2):333-340. PubMed ID: 29614699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transcranial parenchymal sonography in the diagnosis of Parkinson's disease].
    Mijajlović M; Petrović I; Stojković T; Svetel M; Stefanova E; Kostić VS
    Vojnosanit Pregl; 2008 Aug; 65(8):601-5. PubMed ID: 18751340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substantia nigra hyperechogenicity does not correlate with motor features in Parkinson's disease.
    Jesus-Ribeiro J; Sargento-Freitas J; Sousa M; Silva F; Freire A; Januário C
    J Neurol Sci; 2016 May; 364():9-11. PubMed ID: 27084206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substantia nigra hyperechogenicity in depressive subjects relates to motor asymmetry and impaired word fluency.
    Hoeppner J; Prudente-Morrissey L; Herpertz SC; Benecke R; Walter U
    Eur Arch Psychiatry Clin Neurosci; 2009 Mar; 259(2):92-7. PubMed ID: 18806917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcranial sonography image characteristics in different Parkinson's disease subtypes.
    Sheng AY; Zhang YC; Sheng YJ; Wang CS; Zhang Y; Hu H; Luo WF; LIu CF
    Neurol Sci; 2017 Oct; 38(10):1805-1810. PubMed ID: 28726052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The measuring of substantia nigra hyperechogenicity in an Italian cohort of Parkinson disease patients: a case/control study (NOBIS Study).
    Prati P; Bignamini A; Coppo L; Naldi A; Comi C; Cantello R; Gusmaroli G; Walter U
    J Neural Transm (Vienna); 2017 Jul; 124(7):869-879. PubMed ID: 28451942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Age on Substantia Nigra Hyper-echogenicity in Parkinson's Disease Patients and Healthy Controls.
    Toomsoo T; Liepelt-Scarfone I; Berg D; Kerner R; Pool AH; Kadastik-Eerme L; Rubanovits I; Asser T; Taba P
    Ultrasound Med Biol; 2019 Jan; 45(1):122-128. PubMed ID: 30482710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcranial brain sonography in Parkinson's disease with restless legs syndrome.
    Kwon DY; Seo WK; Yoon HK; Park MH; Koh SB; Park KW
    Mov Disord; 2010 Jul; 25(10):1373-8. PubMed ID: 20544813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain parenchyma sonography and 123I-FP-CIT SPECT in Parkinson's disease and essential tremor.
    Doepp F; Plotkin M; Siegel L; Kivi A; Gruber D; Lobsien E; Kupsch A; Schreiber SJ
    Mov Disord; 2008 Feb; 23(3):405-10. PubMed ID: 18067184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia.
    Dong ZF; Wang CS; Zhang YC; Zhang Y; Sheng YJ; Hu H; Luo WF; Liu CF
    Chin Med J (Engl); 2017 Oct; 130(19):2291-2295. PubMed ID: 28937033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcranial ultrasound in different monogenetic subtypes of Parkinson's disease.
    Schweitzer KJ; Brüssel T; Leitner P; Krüger R; Bauer P; Woitalla D; Tomiuk J; Gasser T; Berg D
    J Neurol; 2007 May; 254(5):613-6. PubMed ID: 17415511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcranial brain sonography for Parkinsonian syndromes.
    Bor-Seng-Shu E; Paschoal FM; Almeida KJ; De Lima Oliveira M; Nogueira RC; Teixeira MJ; Walter U
    J Neurosurg Sci; 2019 Aug; 63(4):441-449. PubMed ID: 31210040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcranial Brain Sonography in Parkinson's Disease and Other Parkinsonian Disorders: a Hospital Study from Tuzla, Bosnia and Herzegovina.
    Smajlovic D; Ibrahimagic OC
    Med Arch; 2017 Aug; 71(4):261-264. PubMed ID: 28974846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson's disease.
    Schweitzer KJ; Hilker R; Walter U; Burghaus L; Berg D
    Mov Disord; 2006 Jan; 21(1):94-8. PubMed ID: 16114024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.